drugset / Trial / NCT02058446

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

NCT02058446

Phase 4 Completed 36 enrolled TSH Biopharm Corporation Limited
NaSingle-groupOpen-labelTreatment

Summary

The antihypertensive effect of Amlodipine/Valsartan combination has been evaluated in worldwide populations including Asian patients. The study primarily aims to evaluate the effectiveness of Amlodipine/Valsartan combination in patients with essential hypertension in Taiwan using a prospective, open-label, non-randomized approach. The study also wants to investigate the safety of Amlodipine/Valsartan combination during the 6-week treatment period.

Timeline

Start
2013-10
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Valsartan Small molecule 80 mg